The findings come amid growing concerns about pet obesity, with an estimated 60% of UK dogs now overweight or obese.[1] The news follows bio-pharma company Okava's plans to trial a weight-loss drug for dogs that mimics the effects of Ozempic, tapping into a potential $10 billion market.[2] Over half of dog owners aged 25-34 are pro "wag-ovy" Research shows that the most receptive group is dog owners aged 2534, with more than half (56%) saying they would be willing to give their pets a vet-recommended GLP-1 injection
then 72 C for 45 seconds, 72 C for 7 minutes, 4 C for 5 minutes
Sleep more deeply, recover better, and move better in your own body with a peptide plan built around your labs and goals
Key Highlights - If the drug has been approved for over four years and is used with the same diluent, the State Licensing Authority (SLA) may grant permission
Is My Hairline Receding
Tirzepatide, a newer dual-action compound, targets both GLP-1 and GIP receptors, engaging a broader network of metabolic control centers in the brain and gut